Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
PFE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$20.92 - $31.54
Previous CloseN/A
Volume12.20M
Average Volume (3M)52.90M
Market Cap
$129.80B
Enterprise Value$126.67B
Total Cash (Recent Filing)$20.48B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)16.5
Beta0.33
Next Earnings
Aug 05, 2025EPS Estimate
0.56Last Dividend Ex-Date
May 09, 2025Dividend Yield7.4%
Share Statistics
EPS (TTM)0.92
Shares Outstanding5,685,365,700
10 Day Avg. Volume51,243,892
30 Day Avg. Volume52,901,159
Financial Highlights & Ratios
PEG Ratio-7.60
Price to Book (P/B)1.44
Price to Sales (P/S)0.00
P/FCF Ratio13.41
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue0.52
Enterprise Value/Gross Profit3.01
Enterprise Value/Ebitda2.34
Forecast
1Y Price Target
$27.94Price Target Upside22.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe company announced an additional $1.2bn in anticipated savings, for total net cost savings of $5.7bn through 2027.
Dividend CommitmentCFO David Denton reassured investors that the company remains committed to maintaining and growing its dividend over time.
Revenue GrowthVyndaqel represents a significant growth driver for Pfizer, demonstrating strong uptake and contributing meaningfully to revenue.
Bears Say
Political And Economic EnvironmentThe rapidly evolving political and economic environment poses challenges, particularly with potential sector-specific tariffs and regulatory changes.
Regulatory ChallengesThere is concern about recent statements and approaches regarding the FDA that are not aligned with scientific consensus.
Revenue DeclineThe longer-term outlook suggests that PFE does not anticipate strong revenue growth in the next 3 years due to loss of exclusivity on certain products.
---
Ownership Overview
0.03% Insiders
16.91% Mutual Funds
12.03% Other Institutional Investors
50.99% Public Companies and
Individual Investors
PFE FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $20.91 and its highest was $31.54 in the past 12 months.
What is Pfizer’s market cap?
Pfizer’s market cap is $129.80B.
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is Aug 05, 2025 which is in 79 days.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on Apr 29, 2025. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.666 by $0.254.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 7.4%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is 0.56.
How many shares outstanding does Pfizer have?
Pfizer has 5,685,365,700 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.92 in its last earnings report, beating expectations of $0.666. Following the earnings report the stock price went up 3.183%.
Which hedge fund is a major shareholder of Pfizer?
Currently, no hedge funds are holding shares in PFE
---
Pfizer Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.94 (22.38% Upside)
$27.94 (22.38% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 90%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 23.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $84.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Bearish
Bullish news 25%
Bearish news 75%
Bearish news 75%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.77%
12-Months-Change
Fundamentals
Return on Equity
8.62%
Trailing 12-Months
Asset Growth
-5.91%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. is a leading global pharmaceutical corporation headquartered in New York City. It engages in the discovery, development, manufacture, and sale of healthcare products, with a focus on medicines and vaccines. Pfizer operates across multiple therapeutic areas, including oncology, immunology, cardiology, and neurology, and is known for its innovative research and development efforts, contributing to the advancement of healthcare worldwide.
---
PFE Company Deck
---
PFE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Pfizer's earnings call highlighted a strong R&D pipeline and strategic focus on growth areas such as oncology and cardiometabolic segments, alongside significant growth in key products. However, the company also faced challenges, including a decline in overall revenue and potential impacts from global trade uncertainties and competition. Despite these challenges, Pfizer demonstrated strong operational efficiency and cost management, positioning itself for future growth.Read More>---
PFE Revenue Breakdown
47.36% Primary Care
26.17% Specialty Care
24.54% Oncology
1.80% PFIZER CENTREONE
0.13% PFIZER IGNITE
---
PFE Stock 12 Month Forecast
Average Price Target
$27.94
▲(22.38% Upside)
Technical Analysis
---